Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient

Tumor lysis syndrome is rare in hepatocellular carcinoma (HCC), but it has been reported more frequently recently in response to treatments such as transcatheter arterial chemoembolization (TACE), radiofrequency thermal ablation (RFTA), and sorafenib. Tumor lysis syndrome induced by low-dose steroid...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Mol Hepatol
Autores principales: Kim, Jin Ok, Jun, Dae Won, Tae, Hye Jin, Lee, Kang Nyeong, Lee, Hang Lak, Lee, Oh Young, Choi, Ho Soon, Yoon, Byung Chul, Hahm, Joon Soo
Formato: Artigo
Lenguaje:Inglês
Publicado: The Korean Association for the Study of the Liver 2015
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4379202/
https://ncbi.nlm.nih.gov/pubmed/25834806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2015.21.1.85
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares